CardiaTec Secures $6.5M Seed Funding to Advance Its Multi-omics Drug Discovery Platform for Cardiovascular Diseases

Written By Charlotte Kirby
Charlotte Kirby
Previous

PhoreMost extends Series B financing to $50M to advance high-value oncology and inflammation degrader programmes
Next

Qkine expands senior leadership with the appointment of Rob Nixon, Commercial Director, and Paul Grafham, Chief Financial Officer